CompletedNCT00835627
Sertraline, therapy or both for nonepileptic seizures and trauma symptoms
About this title
Read the official source — NCT00835627Medication studyAges 18–95United StatesDissociative disorders
Understand this study
Who was this study for?
Listed age limits: 18 years to 95 years.
- Listed locations
- Stanford and 2 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateSeptember 2008
- Recruitment status
- Completed
- Enrollment listed in the registry
- 38
- Sponsor
- Rhode Island Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Behavioural, Drug, Other
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 95 Years
- Official registry ID
- NCT00835627
- Official title
Show the full official title
Medication and Psychotherapy Treatment Trial for Psychogenic Nonepileptic Seizures
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Stanford · Cincinnati · Providence
Registry details
Registry conditions (original wording)
Convulsion, Non-Epileptic; Conversion Disorder; Depression; Stress Disorders, Post-Traumatic; Dissociative Disorders
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Rhode Island Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including sertraline.
Who was this study for?
Listed age limits: 18 years to 95 years.
